Skip to main content
. 2016 May 26;68(6):744–752. doi: 10.1002/acr.22759

Figure 1.

Figure 1

The proportions of patients with A) American College of Rheumatology 20% improvement criteria (ACR20) response or B) ACR50 response through week 256. MTX = methotrexate.